Jiangxi Institute of Biological Products (HKSE:06915) Dividends per Share: HK$0.00 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06915 Jiangxi Institute of Biological Products Inc HKSE:06915
23 GF Score
Price HK$16.72
! 3 Warning Signs
View Full Analysis

What is Jiangxi Institute of Biological Products Dividends per Share?

Jiangxi Institute of Biological Products HKSE:06915 +1.33% 23 Dividends per Share is HK$0.00 as of Dec. 2025. GuruFocus rates HKSE:06915 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Jiangxi Institute of Biological Products's dividends per share for the six months ended in Dec. 2025 was HK$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00. As of today, Jiangxi Institute of Biological Products's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Jiangxi Institute of Biological Products  (HKSE:06915) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Jiangxi Institute of Biological Products's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0/ 0.392
=0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Institute of Biological Products Dividends per Share Related Terms

Jiangxi Institute of Biological Products Dividends per Share Historical Data

* Premium members only.

The historical data trend for Jiangxi Institute of Biological Products's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Institute of Biological Products Dividends per Share Chart

Jiangxi Institute of Biological Products Annual Data
Trend Dec23 Dec24 Dec25
Dividends per Share
0.00 0.00 0.00

Jiangxi Institute of Biological Products Semi-Annual Data
Dec23 Dec24 Dec25
Dividends per Share 0.00 0.00 0.00

HKSE:06915 vs LLY, JNJ, ABBV: Dividends per Share Comparison

For the Drug Manufacturers - General subindustry, Jiangxi Institute of Biological Products's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangxi Institute of Biological Products Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangxi Institute of Biological Products's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Jiangxi Institute of Biological Products's Dividend Yield % falls into.


HKSE:06915
23GF Score
Jiangxi Institute of Biological Products Inc HKSE:06915
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangxi Institute of Biological Products Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of HK$0.00 mean?
Jiangxi Institute of Biological Products (HKSE:06915) has a Dividends per Share of HK$0.00 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Jiangxi Institute of Biological Products and its competitors.
Is Jiangxi Institute of Biological Products' Dividends per Share too high?
Jiangxi Institute of Biological Products' current Dividends per Share is HK$0.00. Overall, Jiangxi Institute of Biological Products has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Institute of Biological Products' Dividends per Share compare to LLY and JNJ?
Jiangxi Institute of Biological Products' Dividends per Share of HK$0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Jiangxi Institute of Biological Products and its competitors. Jiangxi Institute of Biological Products's current Dividends per Share is HK$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Institute of Biological Products stock overvalued right now?
Jiangxi Institute of Biological Products (HKSE:06915) has a current Dividends per Share of HK$0.00. The current Dividends per Share is HK$0.00. Jiangxi Institute of Biological Products' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Jiangxi Institute of Biological Products (HKSE:06915), the current Dividends per Share is HK$0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jiangxi Institute of Biological Products Business Description

Address No. 198 Huoju Avenue, Jinggangshan Economic and Technological Development Zone, Jiangxi Province, Ji’an, CHN
Jiangxi Institute of Biological Products Inc is principally engaged in the business of research and development, and production and sale of human tetanus antitoxin. It operates as the provider and exporter of Human TAT in China and an antiserum platform company. Its products include biological products containing immunoglobulins or immunoglobulin F(ab')2 fragments, which are used in medical applications such as tetanus, snakebite envenoming, and rabies treatment. The majority of the company's revenue is derived from the sale of Human Tetanus Antitoxin in the Chinese mainland.
23GF Score

Get the complete analysis for HKSE:06915

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$16.72
Price